Clinical pharmacology of theophylline in preterm infants: Effects, metabolism and pharmacokinetics

Current Pediatric Reviews

Volumn 10, Issue 4, 2014, Pages 297-303

  Pacifici, Gian Maria ^a  

^a NONE   (Italy)

Author keywords

Development; Effects; Metabolism; Neonate; Pharmacokinetics; Theophylline

Indexed keywords

CAFFEINE; THEOPHYLLINE; BRONCHODILATING AGENT;

APNEA; ARTICLE; DEMETHYLATION; DIURESIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG MONITORING; DRUG SALIVA LEVEL; HUMAN; HYPOXEMIA; KIDNEY DYSFUNCTION; METHYLATION; PREMATURITY; PRIORITY JOURNAL; SLEEP WAKING CYCLE; VOLUME OF DISTRIBUTION; BRAIN; CHEMISTRY; DRUG EFFECTS; KIDNEY; LUNG; METABOLISM; NEWBORN; SALIVA; SLEEP;

APNEA; BRAIN; BRONCHODILATOR AGENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY; LUNG; SALIVA; SLEEP; THEOPHYLLINE;

EID: 84924862528     PISSN: 15733963     EISSN: 18756336     Source Type: Journal    
DOI: 10.2174/1573396311666150113213352     Document Type: Article

References (43)

1. [1] Neonatal Formulary. 6th ed. John Wiley & Sons, Limited European Distribution Centre New Era Estate, Oldlands Way Bognor Regis, West Sussex, PO22 9NQ, UK. 2011, pp 256.
2. [2] Persson CG, Draco AB. Xanthines as airway anti-inflammatory drugs. J Allergy Clin Immunol 1988; 81(3): 615-7.
3. [3] Persson CG. Overview of effects of theophylline. J Allergy Clin Immunol 1986; 78(4 Pt 2): 780-7.
4. [4] Melmon KL, Morelli HF, Hoffman BB, Nierenberg DW, Eds. Melmon and Morelli’s Clinical Pharmacology. 3rd ed. 1992. New York: USA, pp194-8.
5. [5] Eslami Z, Shajari A, Kheirandish M, Heidary A. Theophylline for prevention of kidney dysfunction in neonates with severe asphyxia. Iran J Kidney Dis 2009; 3(4): 222-6.
6. [6] Cattarelli D, Spandrio M, Gasparoni A, Bottino R, Offer C, Chirico G. A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 2006; 91(2): F80-4.
7. [7] Al-Wassia H, Alshaikh B, Sauve R. Prophylactic theophylline for the prevention of severe renal dysfunction in term and post-term neonates with perinatal asphyxia: a systematic review and metaanalysis of randomized controlled trials. J Perinatol 2013; 33(4): 271-7.
8. [8] Malk K, Metsäranta M, Vanhatalo S. Drug effects on endogenous brain activity in preterm babies. Brain Dev 2014; 36(2): 116-23.
9. [9] Merchant RH, Sakhalkar VS, Ashavaid TF. Prophylactic theophylline infusion for prevention of apnea of prematurity. Indian Pediatr 1992; 29(11): 1359-63.
10. [10] Muttitt SC, Tierney AJ, Finer NN. The dose response of theophylline in the treatment of apnea of prematurity. J Pediatr 1988; 112(1): 115-21.
11. [11] du Preez MJ, Botha JH, McFadyen ML, Adhikari M. The effect of theophylline on apnoea and hypoxaemic episodes in the premature neonate during the 1st 3 days after birth. Ann Trop Paediatr 1998; 18(3): 217-24.
12. [12] Paky F, Donath P, Huebmer E, Stögmann W. Theophylline for infants with abnormal pneumographic results. A randomized double blind, placebo-controlled trial. Klin Padiatr 1997; 209(2): 66-70.
13. [13] Milerad J. Effects of theophylline on ventilatory response to hypoxic challenge. Arch Dis Child 1987; 62(12): 1242-6.
14. [14] Wasunna A. Effects of theophylline administration and intracranial abnormalities on protective head turning response in preterm infants. East Afr Med J 2003; 80(4): 204-6.
15. [15] Thoman EB, Davis DH, Raye JR, Philipps AF, Rowe JC, Denenberg VH. Theophylline affects sleep-wake state development in premature infants. Neuropediatrics 1985; 16(1): 13-8.
16. [16] Tserng KY, King KC, Takieddine FN. Theophylline metabolism in premature infants. Clin Pharmacol Ther 1981; 29(5): 594-600.
17. [17] Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV. Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr 1979; 94(6): 988-93.
18. [18] Baird-Lambert J, Doyle PE, Thomas D, Jager-Roman E, Cvejic M, Buchanan N. Theophylline metabolism in preterm neonates during the first weeks of life. Dev Pharmacol Ther 1984; 7(4): 239-44.
19. [19] Lönnerholm G, Lindström B, Paalzow L, Sedin G. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life. Eur J Clin Pharmacol 1983; 24(3): 371-4.
20. [20] Kraus DM, Fischer JH, Reitz SJ, Kecskes SA, Yeh TF, McCulloch KM, Tung EC, Cwik MJ. Alterations in theophylline metabolism during the first year of life. Clin Pharmacol Ther 1993; 54(4): 351-9.
21. [21] Chaudhuri M, Garg SK, Narang A, Bhakoo ON. Kinetics of theophylline in apnea of prematurity in small for gestational age babies. Indian Pediatr 1996; 33(3): 181-7.
22. [22] Gilman JT, Gal P, Levine RS, Hersh CB, Erkan NV. Factors influencing theophylline disposition in 179 newborns. Ther Drug Monit 1986; 8(1): 4-10.
23. [23] Dothey CI, Tserng KY, Kaw S, King KC. Maturational changes of theophylline pharmacokinetics in preterm infants. Clin Pharmacol Ther 1989; 45(5): 461-8.
24. [24] Kandrotas RJ, Cranfield TL, Gal P, Ransom JL, Weaver RL. Effect of phenobarbital administration on theophylline clearance in premature neonates. Ther Drug Monit 1990; 12(2): 139-43.
25. [25] Franko TG, Powell DA, Nahata MC. Pharmacokinetics of theophylline in infants with bronchiolitis. Eur J Clin Pharmacol 1982; 23(2): 123-7.
26. [26] Murphy MG, Peck CC, Conner DP, Zamani K, Merenstein GB, Rodden D. Transcutaneous theophylline collection in preterm infants. Clin Pharmacol Ther 1990; 47(4): 427-34.
27. [27] Micali G, Bhatt RH, Distefano G, Caltabiano L, Cook B, Fischer JH, Solomon LM, West DP. Evaluation of transdermal theophylline pharmacokinetics in neonates. Pharmacotherapy 1993; 13(4): 386-90.
28. [28] Evans NJ, Rutter N, Hadgraft J, Parr G. Percutaneous administration of theophylline in the preterm infant. J Pediatr 1985; 107(2): 307-11.
29. [29] Chereches-Panta P, Nanulescu MV, Culea M, Palibroda N. Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity. J Perinatol 2007; 27(11): 709-12.
30. [30] Toback JW, Gal P, Erkan NV, Roop C, Robinson H. Usefulness of theophylline saliva levels in neonates. Ther Drug Monit 1983; 5(2): 185-9.
31. [31] Lowry JA, Jarrett RV, Wasserman G, Pettett G, Kauffman RE. Theophylline toxicokinetics in premature newborns. Arch Pediatr Adolesc Med 2001; 155(8): 934-9.
32. [32] Skopnik H, Bergt U, Heimann G. Neonatal theophylline intoxication: pharmacokinetics and clinical evaluation. Eur J Pediatr 1992; 151(3): 221-4.
33. [33] Shannon M, Lovejoy FH Jr. Hypokalemia after theophylline intoxication. The effects of acute vs chronic poisoning. Arch Intern Med 1989; 149(12): 2725-9.
34. [34] Simons FE, Friesen FR, Simons KJ. Theophylline toxicity in term infants. Am J Dis Child 1980; 134(1): 39-41.
35. [35] Ogilvie RI. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 1978; 3(4): 267-93.
36. [36] Weinberger M. The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol 1984; 73(5 Pt 1): 525-40.
37. [37] Moore ES, Faix RG, Banagale RC, Grasela TH. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm 1989; 17(1): 47-66.
38. [38] Ahn HW, Shin WG, Park KJ, Suh OK, Choi JH. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea. Res Commun Mol Pathol Pharmacol 1999; 105(1 2): 105-13.
39. [39] Islam SI, Ali AS, Sheikh AA, Fida NM. Pharmacokinetics of theophylline in preterm neonates during the first month of life. Saudi Med J 2004; 25(4): 459-65.
40. [40] Aranda JV, Sitar DS, Parsons WD, Loughnan PM, Neims AH. Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 1976; 295(8): 413-6.
41. [41] Giacoia G, Jusko WJ, Menke J, Koup JR. Theophylline pharmacokinetics in premature infants with apnea. J Pediatr 1976; 89(5): 829-32.
42. [42] Hilligoss DM, Jusko WJ, Koup JR, Giacoia G. Factors affecting theophylline pharmacokinetics in premature infants with apnea. Dev Pharmacol Ther 1980; 1(1): 6-15.
43. [43] Stile IL, Zolfaghari S, Hiatt IM, Hegyi T. Pharmacokinetics of theophylline in premature infants on the first day of life. Clin Ther 1986; 8(3): 336-41.